...  But the approval … Read more on Motley Fool  Can Ariad Survive on 2 Drugs? Filed under: drug treatment news articles The leader: Ponatinib Ariad's ponatinib is an oral leukemia treatment that has received priority review status from the Food and Drug Administration; the agency is expected to rule on the drug's application in March. Ariad is entering this market at a … Read more on Motley Fool Tags: medullary thyroid cancer, drug treatment, motley fool, news article ...